First Header Logo Second Header Logo

Connection

Roy Hantgan to Tissue Plasminogen Activator

This is a "connection" page, showing publications Roy Hantgan has written about Tissue Plasminogen Activator.
Connection Strength

0.137
  1. Huang TC, Jordan RE, Hantgan RR, Alevriadou BR. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions. Thromb Res. 2001 Jun 01; 102(5):411-25.
    View in: PubMed
    Score: 0.042
  2. Hantgan RR, Jerome WG, Hursting MJ. No effect of clot age or thrombolysis on argatroban's inhibition of thrombin. Blood. 1998 Sep 15; 92(6):2064-74.
    View in: PubMed
    Score: 0.035
  3. Hantgan RR, Jerome WG, Handt S. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus. Thromb Haemost. 1998 Mar; 79(3):602-8.
    View in: PubMed
    Score: 0.034
  4. Braaten JV, Jerome WG, Hantgan RR. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface. Blood. 1994 Feb 15; 83(4):982-93.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.